RecruitingNot ApplicableNCT02671448

Pilot Trial of Homebound Stem Cell Transplantation


Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

91 participants

Start Date

Jan 1, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

In this study, the investigators plan to see what happens when a person receives care in the home setting. They want to find out if caring for a patient who has been treated with an ASCT in the home setting is feasible. They want to find out what effects good and/or bad this will have on the patient's recovery and treatment after ASCT. Studies in other institutions have shown that providing care in the home setting after ASCT is safe, increases patient satisfaction, and can decrease the risk of infection. It is our hope that this new approach of providing care in the home setting will prove to be a feasible and safe option for patients at Memorial Sloan Kettering Cancer Center (MSK).


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This pilot study is testing whether patients who need a stem cell transplant (bone marrow transplant) can safely receive it and recover at home instead of staying in the hospital, by providing close nursing and medical support in the home setting. **You may be eligible if...** - You need a stem cell transplant (using your own cells — called autologous transplant) for a blood cancer or related condition - You live within a reasonable distance from the transplant center - You have a caregiver at home who can assist you during recovery - Your home environment meets basic safety and sanitation requirements - You are otherwise in adequate health to attempt outpatient recovery **You may NOT be eligible if...** - You live too far from the transplant center for emergency support - You do not have a reliable caregiver at home - Your home environment is unsuitable (e.g., no running water, uncontrolled pests) - You have a condition requiring constant in-hospital monitoring - You are not comfortable managing your own care at home with nursing support Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALHome monitoring teleconsult visits

A tablet will be provided to both the patient and the caregiver during the homecare portion of the study. The tablet will remain at the home, to be used by the patient and the caregiver during daily homecare visits to complete instruments/surveys and video diary recording sessions.

BEHAVIORALPatient Reported Outcomes (PRO)

Distress Thermometer, MSK-Modified M.D. Anderson Symptom Inventory (MDASI) Instrument, FACT-G Instrument, FACT-BMT Instrument

BEHAVIORALCaregiver Reported Outcomes instruments

Distress Thermometer, Caregiver Reaction Assessment (CRA) Instrument, The Caregiver Quality of Life Index-Cancer (CQOLC) Scale, Satisfaction Questionnaire, Video Diary Entries


Locations(1)

Memorial Sloan Kettering Cancer Center

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02671448


Related Trials